Sign in
CompletedNo phase

Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication

Key facts

Who runs it
Yueyue Li
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
1,730 people enrolled
Started
1 Jan 2022
Ended
31 Jul 2025
Type of study
Observational, 2 groups
Treatments tested
  • This study is a retrospective study, and all data have been collected in advance with no active intervention required.
Record updated
11 September 2025

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • patients aged 18-70 years, regardless of gender
  • absent history of receiving H. pylori eradication therapy
  • diagnosed with H. pylori infection through at least one of the following methods: rapid urease test, ¹³C/¹⁴C-urea breath test, or histopathological examination

Who cannot take part

  • patients who received treatment regimens that did not comply with the quadruple regimens specified in this study
  • patients with incomplete medical records, including missing treatment details, absence of post-treatment follow-up test results, or failure to complete essential follow-up assessments

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Bismuth-containing quadruple therapy was recommended as a first-line treatment for Helicobacter pylori infection. This study aimed to compare real-world outcomes of various bismuth-containging quadruple regimens and identify factors influencing treatment failure. A multicenter retrospective analysis was conducted and study outcomes included eradication rates and incidence of adverse events.

The 2 groups in the trial

  • vonoprazan-based quadruple therapies

    Treatment: This study is a retrospective study, and all data have been collected in advance with no active intervention required.

  • tegoprazan-based quadruple therapies

    Treatment: This study is a retrospective study, and all data have been collected in advance with no active intervention required.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy and Safety of Bismuth-containing Quadruple Therapy for First Line Helicobacter Pylori Eradication: A Multicenter Retrospective Study
Record updated
11 September 2025